DMUC4064A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMUC4064A, covering 2018-06-21 to 2018-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]

See pricing